AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Discover ways to earn while saving money that can enhance your financial stability. Start implementing these strategies now.
27,542 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
As Micron prepares for its quarterly update, investors face a crossroads between potential volatility and opportunity...
Oil prices drop to a three-month low following news of a Trump Iran framework, signaling potential relief for inflati...
Global markets edge higher as AI capex momentum remains strong. Economists say momentum outweighs iran risks even as ...
A veteran market commentator shines a light on a legacy chipmaker as a serious AI play. This analysis weighs the case...
Dexe surged about 50% in a single session despite a broad market downturn, trading near the mid-20s as traders evalua...
SBI Group introduces JPYSC, a trust-bank-backed stablecoin pegged to the yen. Access is limited to SBI VC Trade custo...
Cerebras Systems stock crashed after its latest earnings report, leaving investors asking what happened and what come...
A smart investor finds a meet growth stock that's cheaper than six Magnificent Seven names, backed by solid growth an...
May data from the MBA shows mortgage payments rising 2.2% as rate moves and bigger loan applications weigh on buyers....
Moscow has launched a limited, state-backed crypto settlement corridor for select foreign-trade partners, testing ho...
NVIDIA delivered a blockbuster quarter while Cerebras reported explosive inference speed that still risks negative ma...